Bicycle Therapeutics plc (BCYC) Misses Q1 EPS by 22c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q1 EPS of ($1.30), $0.22 worse than the analyst estimate of ($1.08). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $3.87 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
• Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick